SEC Form 4 · accession 0001140361-18-002371
CHEMBIO DIAGNOSTICS, INC. · CEMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Javan Esfandiari
Officer — Chief Science/Tech Officer
Period of report
Jan 16, 2018
Accepted (ET)
Jan 18, 2018 · 2:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001092662
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 16, 2018 | M | 59,765 | — | A | 129,180 | D | |
| Common Stock | Jan 16, 2018 | F | 37,922 | $8.669 | D | 91,258 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase | $5.44 | Jan 16, 2018 | M | 10,000 | D | Mar 5, 2014 | Mar 5, 2018 | Common Stock | 10,000 | 0 | D |
| Options to Purchase | $5.44 | Jan 16, 2018 | M | 10,000 | D | Mar 5, 2015 | Mar 5, 2018 | Common Stock | 10,000 | 0 | D |
| Options to Purchase | $5.44 | Jan 16, 2018 | M | 10,000 | D | Mar 5, 2016 | Mar 5, 2018 | Common Stock | 10,000 | 0 | D |
| Options to Purchase | $5.64 | Jan 16, 2018 | M | 17,730 | D | Mar 11, 2017 | Mar 11, 2021 | Common Stock | 17,730 | 0 | D |
| Options to Purchase | $5.56 | Jan 16, 2018 | M | 4,765 | D | Feb 26, 2013 | Feb 26, 2018 | Common Stock | 4,765 | 0 | D |
| Options to Purchase | $5.25 | Jan 16, 2018 | M | 5,000 | D | Mar 15, 2017 | Mar 15, 2022 | Common Stock | 5,000 | 0 | D |
| Options to Purchase | $5.64 | Jan 16, 2018 | M | 2,270 | D | Mar 11, 2017 | Mar 11, 2021 | Common Stock | 2,270 | 0 | D |
Explanation of responses
- F1Prices range from $5.25 to $5.64